United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - tioguanine - oral tablet - 40mg

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading ltd. - tioguanine 40 mg - tablet - 40 mg - tioguanine 40 mg - tioguanine

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - tioguanine, quantity: 40 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; stearic acid; magnesium stearate; potato starch; acacia - indications as at 10 october 2005: acute myeloblastic leukaemia. less commonly, chronic granulocytic (myelocytic, myeloid, myelogenous) leukaemia. although superior results are generally obtained with busulphan (myleran) in the treatment of chronic granulocytic leukaemia. lanvis may be useful during blast crises or periods of thrombocytopenia induced by busulphan or other therapy. a degree of cross resistance exists between lanvis (thioguanine) and puri-nethol (mercaptopurine) and generally it is not to be expected that patients who no longer respond to mercaptopurine will respond to thioguanine or vice versa. unlike mercaptopurine the detoxification of lanvis is not dependent on xanthine oxidase, hence therapy with lanvis is not affected by the xanthine oxidase inhibitor, allopurinol (zyloprim). recent evidence suggests that lanvis is particularly useful in concurrent or sequelist combination with other antineoplastic drugs, e.g., cytosine arabinoside. not effective for the treatment of chronic lymphocytic l

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - tioguanine - oral tablet - 40mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - tioguanine - oral tablet - 40mg

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - tioguanine 40mg - tablet - 40 mg - active: tioguanine 40mg excipient: acacia lactose monohydrate magnesium stearate potato starch stearic acid - lanvis is indicated primarily for the treatment of acute leukaemias especially:- · acute myelogenous leukaemia · acute lymphoblastic leukaemia

Ireland - English - HPRA (Health Products Regulatory Authority)

aspen pharma trading limited - tioguanine - tablet - 40 milligram(s) - purine analogues; tioguanine

Israel - English - Ministry of Health

perrigo israel agencies ltd, israel - thioguanine - tablets - thioguanine 40 mg - tioguanine - tioguanine - acute nonlymphocytic leukemia.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - tioguanine - oral tablet - 40mg

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - tioguanine bp - tablet - tioguanine bp 40 mg - antineoplastic agents